Table 5.
Geometric means and percentiles of serum PFOA by demographic characteristics- comparing 18+ in SHOW 2014–2016 with U.S. NHANES 2015–2016
PFOA | n | Geometric mean (95% CI) | 50th (95% CI) | 75th (95% CI) | 90th (95% CI) | 95th (95% CI) | |
---|---|---|---|---|---|---|---|
Age | |||||||
| |||||||
SHOW | 18–39 | 162 | 0.93 (0.82–1.05) | 1.10 (0.90–1.20) | 1.60 (1.40–1.80) | 2.00 (1.90–2.30) | 2.40 (2.00–3.20) |
NHANES | 18–39 | 674 | 1.31 (1.21–1.40) | 1.40 (1.20–1.40) | 2.00 (1.80–2.20) | 2.80 (2.50–3.00) | 3.50 (2.90–3.90) |
SHOW | 40–59 | 208 | 1.28 (1.16–1.41) | 1.30 (1.20–1.50) | 1.80 (1.70–2.10) | 2.60 (2.40–3.10) | 3.30 (2.70–4.60) |
NHANES | 40–59 | 581 | 1.64 (1.53–1.77) | 1.60 (1.40–1.80) | 2.40 (2.10–2.50) | 3.30 (3.10–3.60) | 3.90 (3.50–5.20) |
SHOW | 60+ | 233 | 1.51 (1.38–1.65) | 1.50 (1.40–1.80) | 2.30 (2.10–2.50) | 3.30 (2.80–3.50) | 3.50 (3.40–4.20) |
NHANES | 60+ | 574 | 2.01 (1.81–2.22) | 2.10 (1.90–2.20) | 2.80 (2.60–3.10) | 4.20 (3.60–4.90) | 5.20 (4.60–6.90) |
| |||||||
Sex | |||||||
| |||||||
SHOW | Male | 257 | 1.25 (1.13–1.37) | 1.40 (1.30–1.50) | 1.90 (1.80–2.00) | 2.60 (2.40–3.00) | 3.20 (2.90–3.60) |
NHANES | Male | 865 | 1.85 (1.75–1.96) | 1.90 (1.70–2.00) | 2.60 (2.50–2.70) | 3.40 (3.20–3.60) | 4.10 (3.60–5.010) |
SHOW | Female | 346 | 1.15 (1.06–1.25) | 1.20 (1.10–1.20) | 1.80 (1.70–2.00) | 2.70 (2.40–3.10) | 3.50 (2.90–4.20) |
NHANES | Female | 964 | 1.39 (1.29–1.49) | 1.40 (1.30–1.50) | 2.30 (2.00–2.40) | 3.40 (2.90–3.90) | 4.30 (3.90–6.10) |
| |||||||
Race | |||||||
| |||||||
SHOW | White (Non-Hispanic) | 502 | 1.28 (1.20–1.37) | 1.40 (1.30–1.50) | 1.90 (1.80–2.00) | 2.80 (2.50–3.10) | 3.40 (3.10–4.00) |
NHANES | White (Non-Hispanic) | 563 | 1.72 (1.60–1.84) | 1.80 (1.60–1.90) | 2.60 (2.40–2.70) | 3.50 (3.20–3.80) | 4.60 (3.90–5.60) |
SHOW | Non-White | 100 | 0.90 (0.77–1.05) | 1.00 (0.80–1.10) | 1.40 (1.20–1.80) | 2.00 (1.60–2.50) | 2.40 (2.00–3.00) |
NHANES | Non-White | 1266 | 1.40 (1.34–1.47) | 1.40 (1.30–1.40) | 2.10 (2.00–2.20) | 3.10 (2.80–3.30) | 4.00 (3.60–4.10) |